Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR5K1 Activators

OR5K1 is a protein that is encoded by the OR5K1 gene, and it belongs to the large family of olfactory receptors (ORs). Olfactory receptors are integral membrane proteins and a part of the G protein-coupled receptor (GPCR) superfamily. These receptors are responsible for detecting odorants in the olfactory epithelium, which is the sensory organ for smell located in the nasal cavity.Like other olfactory receptors, OR5K1 is involved in the process of olfactory transduction. This is a molecular mechanism that begins when an odorant molecule binds to the OR5K1 receptor, which is located on the cilia of olfactory sensory neurons. Upon binding, OR5K1 undergoes a conformational change that activates the G protein, specifically a type known as G_olf. The activated G protein then stimulates adenylate cyclase to convert ATP to cyclic AMP (cAMP), which serves as a second messenger.

The increase in cAMP levels leads to the opening of cyclic nucleotide-gated ion channels, resulting in the influx of positive ions, such as sodium and calcium, into the olfactory sensory neuron. This ion entry causes depolarization of the neuron membrane and, if the signal is strong enough, an action potential is generated. The action potential travels along the olfactory neuron to the olfactory bulb in the brain, where the signal is interpreted as a distinct smell.Each olfactory receptor, including OR5K1, tends to bind to specific molecular features of odorant molecules, contributing to the specificity and diversity of scent detection. Humans have a repertoire of approximately 400 functional OR genes, allowing us to detect a wide range of odorous compounds. The intricate combination of different ORs, including OR5K1, responding to various odorants allows the olfactory system to recognize and differentiate a plethora of smells, which is essential for survival, behavior, and the perception of the environment.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin activates adenylyl cyclase, increasing intracellular cAMP levels, which could enhance the signaling of OR5K1 by downstream effects.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX inhibits phosphodiesterases, preventing cAMP breakdown, potentially sustaining OR5K1 signaling through prolonged cAMP signaling.

8-Bromoadenosine 3′,5′-cyclic monophosphate

23583-48-4sc-217493B
sc-217493
sc-217493A
sc-217493C
sc-217493D
25 mg
50 mg
100 mg
250 mg
500 mg
$108.00
$169.00
$295.00
$561.00
$835.00
2
(1)

8-Bromo-cAMP is a cell-permeable cAMP analog that could mimic cAMP in OR5K1 signaling, indirectly enhancing its activity.

PGE2

363-24-6sc-201225
sc-201225C
sc-201225A
sc-201225B
1 mg
5 mg
10 mg
50 mg
$57.00
$159.00
$275.00
$678.00
37
(1)

Prostaglandin E2 (PGE2) elevates cAMP levels in various cell types and might enhance OR5K1 activity through increased cAMP.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Isoproterenol is a beta-adrenergic agonist that can increase cAMP levels, potentially enhancing OR5K1 signaling indirectly.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram inhibits PDE4, leading to an increase in cAMP levels, which may indirectly enhance OR5K1 signaling.

Cilostamide (OPC 3689)

68550-75-4sc-201180
sc-201180A
5 mg
25 mg
$92.00
$357.00
16
(1)

Cilostamide inhibits PDE3, increasing cAMP levels, which may indirectly increase OR5K1 activity through elevated cAMP.

Theophylline

58-55-9sc-202835
sc-202835A
sc-202835B
5 g
25 g
100 g
$20.00
$32.00
$85.00
6
(0)

Theophylline is a phosphodiesterase inhibitor that raises cAMP levels, potentially enhancing OR5K1 signaling.

Vinpocetine

42971-09-5sc-201204
sc-201204A
sc-201204B
20 mg
100 mg
15 g
$55.00
$214.00
$2400.00
4
(1)

Vinpocetine is a PDE1 inhibitor that could increase cAMP levels, potentially enhancing OR5K1 signaling indirectly.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$105.00
$250.00
8
(2)

Zaprinast inhibits PDE5 and to a lesser extent PDE10, which might increase cAMP levels, indirectly enhancing OR5K1 signaling.